Doctors Unite to Support Hyderabad Paediatrician Amid Legal Threat Over ORS Advice
A wave of support is building across the medical community for a Hyderabad-based paediatrician, Dr. Sivaranjani Santosh, who is facing legal notices from pharmaceutical companies over her long-standing campaign on misleading ORS (Oral Rehydration Solution) products.
What Sparked the Controversy?
For nearly a decade, Dr. Sivaranjani has been raising concerns about high-sugar beverages being marketed as ORS, arguing that such products can be harmful—especially for children.
Recently, two pharmaceutical companies issued cease-and-desist notices, accusing her of making defamatory statements and demanding that she stop her public advocacy.
The companies, however, maintain that their products comply with regulatory standards and are backed by scientific evidence.
Medical Community Calls It “Intimidation”
The legal action has triggered strong reactions from doctors and healthcare organizations across the country.
Medical associations have described the notices as:
- “Unwarranted”
- An “attempt to intimidate” a doctor
- A move that could silence public health advocacy
Many professionals argue that raising concerns about patient safety should not lead to legal threats, especially when backed by scientific reasoning and regulatory discussions.
Backed by Regulations and Public Support
Dr. Sivaranjani has defended her stance, stating that her claims are aligned with Food Safety and Standards Authority of India (FSSAI) directives, which restrict the misuse of the term “ORS” for non-compliant products.
Her years-long campaign even contributed to stricter regulations on labeling, highlighting the impact of sustained public health advocacy.
Meanwhile, support has extended beyond the medical community, with:
- Social media campaigns like #StandWithDrSivaranjani
- Backing from parents and public health advocates
A Bigger Debate: Public Health vs Legal Pressure
This issue has now grown into a broader debate about:
- The role of doctors in public advocacy
- Corporate accountability in healthcare
- Whether legal notices can discourage professionals from speaking out
For many, the case represents a critical moment for medical freedom and patient safety.
Why This Matters
At its core, the controversy is not just about one doctor—it’s about whether health professionals can openly challenge practices they believe may harm patients.
As the debate continues, the strong support for Dr. Sivaranjani shows that the medical community is standing firm on one principle:
👉 Patient safety should always come first.
